Skip to content
Peptigraph home

IGF-1 LR3 for Muscle Growth: What the Evidence Shows

What human and animal studies show about IGF-1 LR3 for muscle growth, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureIGF-1 analogUpdated
Strongest evidence
Animal
Human studies
0
PubMed records, our ledger
Animal studies
6
PubMed records, our ledger
Studies we summarised
8
with an outcome for muscle growth

Evidence for muscle growth

Each row is an outcome related to muscle growth from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

IGF-1 LR3 for muscle growth: outcomes in published studies
OutcomeResultStudy typeSource
Regulatory status and evidence for physique claimsThe review notes no regulatory approval for physique- or performance-related indications of these peptides, including the long-acting IGF analogue.ReviewFrontiers in endocrinology 2026, PMID 42395176
Fetal growthOne week of IGF-1 LR3 did not improve growth in growth-restricted fetal sheep.Animal · sheep (not a human result)n = 14American journal of physiology. Endocrinology and metabolism 2025, PMID 39679943
Body composition and cognitionIntranasal LR3-IGF-1 improved body composition (not specified in the abstract) in male 5XFAD mice but did not significantly change cognition.Animal · mouse (not a human result)Journal of Alzheimer's disease 2025, PMID 39610283
Daily weight gainIn the second 9 days, LR3IGF-I-infused neonatal pigs gained 457 g/d versus 386 g/d for controls.Animal · pig (not a human result)The British journal of nutrition 2002, PMID 12067429
Growth performanceA four-day infusion of 180 micrograms/kg/day LR3IGF-I decreased average daily gain, food intake and plasma IGFBP-3, IGF-I and insulin in pigs.Animal · pig (not a human result)The Journal of endocrinology 1997, PMID 9488001
Overall growthFractional weights of adrenals, gut, kidneys and spleen increased with LR3IGF-I, but overall growth was not stimulated.Animal · guinea pig (not a human result)The Journal of endocrinology 1995, PMID 7561636
Carcass proteinLR3-IGF-I had no positive effect on carcass protein accretion in tumour-bearing rats.Animal · rat (not a human result)The Biochemical journal 1994, PMID 8053901
Growth in diabetic ratsThe IGF-I variants were 2.5-3 times more potent than IGF-I at restoring growth in diabetic rats.Animal · rat (not a human result)The Biochemical journal 1993, PMID 7683875
Muscle protein synthesisAll IGF peptides raised muscle protein-synthesis rates and RNA levels by up to 50%, IGF-I least.Animal · rat (not a human result)The Biochemical journal 1993, PMID 7683875

PubMed records for IGF-1 LR3 and muscle growth: 0 human, 6 animal (search counts, not studies we reviewed). Grades follow our .

How strong is it?

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Muscle growth in everyday terms

MedlinePlus lists weights, resistance bands and your own body weight as the tools of strength training.[9]

No human muscle trial exists for IGF-1 LR3

The muscle PubMed query for Long R3 or LR3 with IGF terms (run 2026-10-02) found 0 human records, 6 animal records, 0 randomized trials and 7 in total.

Calculated from human 0; animal 6; rct 0; all 7. Formula: Counts copied from the igf-1-lr3 ledger row of the muscle-growth goal in goals.json; no arithmetic.

The one human item is a case report that identified a His-tagged Long-R3-IGF-I in an injection vial and noted its effects in humans have not been described.[10]

What animal studies show, species by species

In streptozotocin-diabetic rats, the LR3 variant and a truncated variant were 2.5 to 3 times more potent than IGF-I at restoring growth.[8]

In the same rats every peptide raised muscle protein synthesis rates by up to 50%.[8]

In tumour-bearing rats, tumour growth was increased by the IGFs, especially LR3-IGF-I, though the peptides did not promote growth of the adenocarcinoma in cell culture.[7]

In finisher pigs, an LR3-IGF-I infusion decreased average daily gain and food intake.[5]

In guinea pigs infused for a week, overall growth was not stimulated, though adrenals, gut, kidneys and spleen became relatively heavier.[6]

In neonatal pigs, daily weight gain over the second 9 days was higher in LR3IGF-I-infused pigs (457 vs 386 g/d); this is body weight, not a muscle measurement.[4]

In growth-restricted fetal sheep, a week of IGF-1 LR3 did not improve growth.[2]

Sport and product-quality notes

IGF-1 (mecasermin) and its analogues are named in WADA's list.[11]

Other peptides people research for muscle growth

All peptides for muscle growth, compared

Common questions

Does IGF-1 LR3 help with muscle growth?

The strongest study we summarise for muscle growth is animal evidence, across 8 studies with an outcome for muscle growth. That is not proof it works in people.

Is IGF-1 LR3 approved for muscle growth?

No. IGF-1 LR3 is not FDA approved for any use, including muscle growth.

What is the best peptide for muscle growth?

There is no single answer. Our muscle growth overview compares each candidate by evidence grade and legal status rather than by popularity.

Does IGF-1 LR3 build muscle?

The ledger shows no human muscle study; in animals, results range from higher muscle protein synthesis in diabetic rats to lower daily gain in finisher pigs.[5]

Is IGF-1 LR3 used for bodybuilding?

A review of performance-related peptide use lists IGF-1 LR3 among the analogues; no study cited here shows a bodybuilding effect in people.[1]

Is IGF-1 LR3 banned?

Yes: the WADA list prohibits IGF-1 and its analogues.[11]

Does IGF-1 build muscle in people?

Not in the one placebo-controlled trial in recreational athletes, which gave a human IGF-I and binding protein complex (not LR3) and found no significant change in lean body mass in women or men. This is separate from LR3, which has no human muscle trial.[12]

More on IGF-1 LR3

Sources

  1. 1The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Frontiers in endocrinology · 2026PMID 42395176Accessed 2 Oct 2026
  2. 2IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.American journal of physiology. Endocrinology and metabolism · 2025PMID 39679943Accessed 2 Oct 2026
  3. 3Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice.Journal of Alzheimer's disease : JAD · 2025PMID 39610283Accessed 2 Oct 2026
  4. 4Insulin-like growth factor-I and analogues increase growth in artificially-reared neonatal pigs.The British journal of nutrition · 2002PMID 12067429Accessed 2 Oct 2026
  5. 5Long [R3] insulin-like growth factor-I reduces growth, plasma growth hormone, IGF binding protein-3 and endogenous IGF-I concentrations in pigs.The Journal of endocrinology · 1997PMID 9488001Accessed 2 Oct 2026
  6. 6Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig.The Journal of endocrinology · 1995PMID 7561636Accessed 2 Oct 2026
  7. 7Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats.The Biochemical journal · 1994PMID 8053901Accessed 2 Oct 2026
  8. 8Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects.The Biochemical journal · 1993PMID 7683875Accessed 2 Oct 2026
  9. 9Official web pageOfficial web page · web page
  10. 10Detection of His-tagged Long-R³-IGF-I in a black market product.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2010PMID 20675162Accessed 2 Oct 2026
  11. 11World Anti-Doping Code International Standard Prohibited List 2026 (in effect 1 January 2026)World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  12. 12The Effects of Recombinant Human Insulin-Like Growth Factor-I/Insulin-Like Growth Factor Binding Protein-3 Administration on Body Composition and Physical Fitness in Recreational Athletes.The Journal of clinical endocrinology and metabolism · 2015PMID 26046967Accessed 25 Oct 2026

Found an error? Report a correction.